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Colonoscopy in adult cystic fibrosis: A 24-year experience in a single 
CF centre 
H. Chaun 1, D. Owen 2, P. Zet let 2 
~Department of Medicine (Gastroenterology & Adult CF Clinic), 2Department of 
Pathology, University of British Columbia, l/~neouver; B.C, Ca~uala 
Intestinal symptoms are common in cystic fbrosis (CF) patients, and abdominal 
pain is a significant cause of morbidity. A IM of this study is to review the 
indications and the frequency of abnormal findings in adult CF patients investigated 
with colonoscopy and biopsies. ME~IODS:  Since 1980, 112 patients have been 
referred to Gastroenterology from the Adult CF Clinic. A retrospective chart review 
showed 60 colonoscopies were performed ha 30 patients, single colonoscopy in 18, 
2 ha 8, multiple in 4 patients. 20 were females, 10 males, age range19 57 years 
(mean 29.5). Primary indication was abdominal pain 16, bleeding or anemia 7, 
d imlhea 3, fi¥ ohn's disease 2, previous colonic cancer 1, previous igmoid resection 
and coloslomy 1, bowel dysfunction 1, abnormal barium enema 1. RESULTS: 14 
patients had abnormal colonoscopy acute segmental colitis 2, prcctitis 1, Crohn's 
2 (both with granulomata), diverticulosis 1, previous resection for carcinoma 1, 
polyps 4 (adenoma 3, juveni le 1), obstructive colonic carcinoma 1, enlarged 
appendix with impacted fecolith 1, DIOS 1 .24  patients had complete colonoscopy 
(to terminal i leum or cecum) mad biopsies 14 had right sided microscopic olitis, 
including 10 with abdominal pain. There were no complications. CONCLUSION: 
20/30 patients (66.6%) had abnormal colonoscopic and/or biopsy findings. Most 
importantly, carcinoma was diaguosed in 1, another had previous resection for 
colonic cancer; 3 had tubular or tubulovil lous adenoma; 2 had Crohn's disease. 14 
had right sided microscopic colitis, cl inical significance undetermined, 10 of whom 
had abdominal pain. Colonoscopy is a safe and essential investigation ha adult CF 
patients with obscure intestinal s3,mpt oms. 
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The prevalence and risk factors for the development of cystic fibrosis 
related liver disease 
S. Fustik 1, M. Tr aj kovska 1, N. Slaveska 1,T. Josifovska 1, S. Kcceva 9, G Efremov 9
iClinicaI Centre, Skopje, 2RCGEB, MASA, Skopje, R. Macedonia 
Liver disease (LD) in cystic fibrosis (CF) has become a matter of greater concern 
since the population of CF patients lives longer. The aim of this study was to define 
the prevalence and the role of possible cl inical and genetic r isk factors for the 
development of CF related LD. Al l  patients older than 3 years (n 52) followed at 
the CF Centre in Skopje were screening for LD through clinical, biochemical, 
ehographic, and hepatobiliary scintigraphic assessment. LD  was defined by the 
f inding of hepatomegaly and/or splenomegaly; significant and persistent increased 
of at least two serum l iver enzyme levels; suggest ive ultrasonographic 
abnormalit ies (score >4); mad morphologic or funct ional  scintigraphic 
abnormalities. According to our predefined criteria, 18 patients (34.6%) were 
classified as having LD, three of them with portal hypertension. Cl inical 
presentations of LD had 6 (33.3%), abnormal l iver blood test results 12 (66.6%), 
ultrasound abnormalities 18 (100%), and scintigraphic abnormalities 13 (72.2%) of 
the patients with LD. Prevalence of LD increased with age (average 13.2+5.3 years 
in the LD group vs 9.9+5.6 years in the no LD group). A male predominance was 
found in the group with LD (72%). Pancreatic insufficiency was present in all 
patients with LD There was no significant difference in the pulmonary function, 
nutritional status, and in the prevalence of meconium ileus or DIOS. Genetic 
analysis how higher frequency of AF508 mutation in LD group (77.8%) vs no LD 
group (66.2%). A l l  patients with LD had severe mutations: AF508, G542X, 
N1303K, CFFRdel.21Kb, 1811+lG >C, and Y1092X. In conclusion, male mad 
older CF patients who have pancreatic insufficiency andcmry mutations associated 
with a severe phenotype are in increased r isk to develop LD. 
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Liver disease in children with cystic fibrosis: prevalence and clinical 
characterisfics 
M.G. Slieker, H.P.J. van der Doef, C.K. van der Ent, R.H.J. Houwen 
CF Center Utrecht, UMC Utrecht, Utrecht, Netherla~uls 
Aims:  CF related liver disease (LD) has been tmiversally asscciated with a severe 
genotype. Some studies described other associations, the most recent being more 
severe lung disease and a general growth failure. In this study we studied the 
prevalence of LD in patients with CF and identified clinical characteristics 
associated with the presence or absence of LD. 
Methods:  The prevalence of LD was calculated using the results of the last yearly 
multidisciplinary checkup.  LD was defined as the presence of at leasCt 2 of the 
fol lowing conditions: hepatomegaly, abnormal serum liver enzyme levels and 
ultrasound abnormalities other than hepatomegaly. A case control sCtudy was 
conducted to identify cl inical characteristics associated with LD. Each child was 
pair matched for sex, date of birth and age with a CF patient without evidence of 
LD. 
Results:  LD was found in 52 of 238 children with CF (22%) aged between 5 and 
19 years. Male gender was more common in patients with LD (58% vs 48%, 
P~).21). The presence of LD was associated with a severe CFTR genotype 
(P<0.001) and with lower height for age (P<0.01). No association between LD and 
a history of meconium ileus, weight or pulmonary function (FEVI, FEVIfFVC , 
RV/TL C and TLC) was found. Analyses of subgroups with severe hepat omegaly or 
liver protein synthesis impairment (factor V<60%) did not al low us to find 
additional associations, although lower height for age was more often observed in 
the latter subgroup (P 0.02). 
Conclusions: The prevalence of LD in chi ldren with CF is high (22%). CF patients 
with LD have more frequently a severe genotype and impaired growth. Contrary to 
some recent studies, in our population the presence of LD was not associated with 
male gender, a history of meconium ileus, pulmonary function or weight. 
292 
Long-term effect of ursodeoxycholic acid on the Cystic Fibrosis 
related Liver Disease 
M. Fotoulaki 1, E. Kotsi 1, K. Vassilaki 1, A. Gall i  Tsinopoulou 1, E. Pavlitou 2, S. 
Nousia Arvanit akis 1 
~Fourth Department of Pediatrics, Aristotle University, Thessaloniki ,GR, 
21mmurtology Lab, Papageotgiou General Hospital, Thessaloniki, GR 
We have demonstrated that ursodeoxycholic acid (UCDA) improved cholestasis 
and hepatic function in nodular bil iary cirrhosis (NBC) and also, reversed the early 
sonographic findings of focal bil iary cirrhosis (FBC) during a 10 year follow up 
period (1990 2000) .The a im of the present study was to further evaluate the effects 
of UCDA on the natural histot3, of NBC in the fol lowing period of 4 years (2001 
2CO4). Mater ia l s  and  methods:  7 CF individuals, aged 12 to 29 years, who had 
NBC, had been followed up regularly and had excellent compliance, underwent 
detailed physical examination, liver function tests and ultrasound liver s~an at six 
month intervals. Hormone profile (estr adiol, andr ostenedione, sex hormone binding 
globulin and prolactin) was measured. The res~alts were compared with those of 
three CF patients aged 12 16 years, who had irregular fol low up and no compliance 
to the physician's instructions. Results:  Liver and spleen size remained stable, l iver 
function tests as wel l  as ful l  blood counts were normal, sonogr aphic f indings did not 
deteriorate mad there was no variceal bleeding in the 7 compliant patients. Hormone 
profile was normal in these patients indicating normal iver function. By contrast, 
the three noncompliant CF NBC patients demonstrated abnormal iver function 
tests; deteriorating portal hypertension with hypersplenism and minor episodes of 
hematemesis they also had increased levels of prolactin. Conclusion: USDA 
administration appears to have a positive influence on the progression of NBC in 
CF patients. 
